Table of Contents: How is Semaglutide GLP-1 administered for weight loss
Common, expected injection site reactions include: Redness or erythema at the injection site Mild swelling or oedema Bruising or haematoma formation Itching or mild discomfort Small, firm nodules beneath the skin (particularly if sites are not rotated) These reactions are typically self-limiting
These drugs include semaglutide (Ozempic for diabetes, Wegovy for weight management), liraglutide (Victoza for diabetes, Saxenda for weight management), dulaglutide (Trulicity for diabetes only), and tirzepatide (Mounjaro for diabetes, Zepbound for weight management)with tirzepatide being a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist, not solely a GLP-1 agonist
It can lead to weight loss, better glycemic control, and reduced cardiometabolic risk factors